-+ 0.00%
-+ 0.00%
-+ 0.00%

InMed Announces Annual General and Special Shareholder Meeting

PUBT·10/27/2026 00:01:59
Listen to the news
InMed Announces Annual General and Special Shareholder Meeting
  • InMed Pharmaceuticals will hold its annual general and special shareholder meeting on November 4, 2026.
  • Shareholders will vote on a return-of-capital proposal covering contingent value rights tied to the proposed Mentari Therapeutics merger.
  • Subject to approval, holders of record on November 5, 2026, would receive one contingent value right per outstanding common share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610262001NEWSFILECNPR____20261026_321032_1) on October 27, 2026, and is solely responsible for the information contained therein.